University of Calgary Creates Canada’s First Chair for Psychedelic Research

University of Calgary Creates Canada’s First Chair for Psychedelic Research

Canada gets its first chair for psychedelic research thanks to private citizen funding to the University of Calgary.
Psilocybin May Treat Phantom Limb Syndrome

80 to 100% of Amputees Experience Phantom Limb Syndrome. Psilocybin May Help.

New research into psychedelics shows psilocybin may help amputees suffering from pain associated with phantom limb syndrome.
Do Psychedelics Hold the Key to Explaining Near-Death Experiences?

Do Psychedelics Hold the Key to Explaining Near-Death Experiences?

New research into psychedelics shows it may help scientists better understand the phenomenon known as near-death experiences.
First Clinical Trial to Treat Frontline Workers Experiencing COVID-Related Distress

Cybin Launches First Clinical Trial to Treat Frontline Workers Experiencing COVID-Related Distress With Psychedelics

A new first-of-its-kind psychedelic study will treat frontline workers experiencing distress related to COVID with psilocybin.
Biotech Firm PsyBio Therapeutics Is Producing Psilocybin From Bacteria

Biotech Firm PsyBio Therapeutics Is Producing Psilocybin From Bacteria

PsyBio Therapeutics is harvesting the psychedelic compound psilocybin from a strain of bacteria instead of mushrooms.
Cybin Taps First-of-Its-Kind Device to Study Psychedelic Effects of Ketamine

Cybin Taps First-of-Its-Kind Device to Study Psychedelic Effects of Ketamine

A new device may help Cybin better understand the psychedelic impact of the drug ketamine on the human brain.
Research Looks at Psychedelics for Autism Treatment

Research to Look at Psychedelics for Autism Treatment

New research from Nova Mentis will explore the potential benefits of psychedelics in treating autism spectrum disorders.
FDA Approves First-Ever MDMA Study for Therapist Volunteers to Better Treat PTSD Patients

FDA Approves First-Ever MDMA Study for Therapist Volunteers to Better Treat PTSD Patients

The FDA has approved a novel study allowing therapists who treat PTSD to take MDMA to better understand the treatment benefits.
UNLV Researchers Discover a Brainwave Signature That Responds to Psychedelic Medicine

Algernon to Become the First Company in the World to Study DMT for Stroke Patients

Algernon Pharmaceuticals has received FDA approval to study DMT for use in stroke patients to help rebuild synaptic connections.
FDA Greenlights Ketamine for Parkinson's Disease Treatment

FDA Green-Lights Ketamine Study for Side Effects of Parkinson’s Disease Treatment

Research into ketamine as a potential treatment for Parkinson's patients suffering from drug side effects is getting FDA approval.